Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Nehme-Álvarez
Institutions:
Research Institute Hospital 12 de Octubre,
Hospital Universitario 12 De Octubre
Observed institutions:
Research Institute Hospital 12 de Octubre,
Hospital Universitario 12 De Octubre
ORCID:
0000-0001-5054-5373
Observed ORCID:
0000-0001-5054-5373
OpenAlex ID:
A5090022768
Synthetic TILs: Engineered Tumor-Infiltrating Lymphocytes With Improved Therapeutic Potential
2021
·
Anaïs Jiménez-Reinoso
, Daniel Nehme-Álvarez
, et al.
·
Frontiers in Oncology
·
45
PDF
An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2021
·
Marta Compte
, Seandean L. Harwood
, et al.
·
Clinical Cancer Research
·
30
Tumor targeted 4-1BB agonist antibody-albumin fusions with high affinity to FcRn induce anti-tumor immunity without toxicity
2022
·
Oana Hangiu
, Marta Compte
, et al.
·
iScience
·
18
PDF
CD4 + tumor-infiltrating lymphocytes secreting T cell-engagers induce regression of autologous patient-derived non-small cell lung cancer xenografts
2024
·
Anaïs Jiménez-Reinoso
, Magdalena Molero-Abraham
, et al.
·
OncoImmunology
·
14
Supplementary Methods from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S6 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S8 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S13 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S4 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S7 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S3 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S1 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S5 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S6 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S1 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Table S4 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S9 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Table S2 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S11 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S10 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S2 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S5 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S12 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Figure S3 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
PDF
Figure S3 from An Fc-free EGFR-specific 4-1BB-agonistic Trimerbody Displays Broad Antitumor Activity in Humanized Murine Cancer Models without Toxicity
2023
·
Marta Compte
, Seandean L. Harwood
, et al.
Show more works
View as search
Works count:
45
Citation count:
107
H-index:
4
I10-index:
4
Year
Topic
Type